Annovis Bio, Inc.盘中异动早盘快速拉升6.13%报12.82美元

自选股智能写手07-11

北京时间2024年07月11日21时31分，Annovis Bio, Inc.（ANVS.us）股票出现异动，股价快速上涨6.13%。截至发稿，该股报12.82美元/股，成交量14.4821万股，换手率1.30%，振幅1.24%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.07百万美元，每股收益-0.10美元，毛利0.00美元，市盈率-2.44倍。机构评级方面，在所有5家参与评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2450500233?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-11 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2450500233","market":"us","top_or_hot":-1,"title":"Annovis Bio, Inc.盘中异动 早盘快速拉升6.13%报12.82美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年07月11日21时31分，Annovis Bio, Inc.（ANVS.us）股票出现异动，股价快速上涨6.13%。截至发稿，该股报12.82美元/股，成交量14.4821万股，换手率1.30%，振幅1.24%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.07百万美元，每股收益-0.10美元，毛利0.00美元，市盈率-2.44倍。机构评级方面，在所有5家参与评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213154aef93ccd&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Annovis Bio, Inc.盘中异动 早盘快速拉升6.13%报12.82美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnnovis Bio, Inc.盘中异动 早盘快速拉升6.13%报12.82美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-11 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213154aef93ccd&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年07月11日21时31分，Annovis Bio, Inc.（ANVS.us）股票出现异动，股价快速上涨6.13%。截至发稿，该股报12.82美元/股，成交量14.4821万股，换手率1.30%，振幅1.24%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.07百万美元，每股收益-0.10美元，毛利0.00美元，市盈率-2.44倍。机构评级方面，在所有5家参与评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213154aef93ccd&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ANVS","symbol_name":"Annovis Bio, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213154aef93ccd&s=b","article_id":"2450500233","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213154aef93ccd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2450500233","pubTimestamp":1720704713,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年07月11日21时31分，Annovis Bio, Inc.股票出现异动，股价快速上涨6.13%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。消息层面，截至21时31分，《H.C. Wainwright维持Annovis Bio买入评级，上调目标价至30美元》资讯为影响Annovis Bio, Inc.的重要信息。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ANVS":"Annovis Bio, Inc.","BK4139":"生物科技"},"translate_title":"Annovis Bio, Inc. quickly rose 6.13% to $12.82 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ANVS":1},"content_text":"北京时间2024年07月11日21时31分，Annovis Bio, Inc.（ANVS.us）股票出现异动，股价快速上涨6.13%。截至发稿，该股报12.82美元/股，成交量14.4821万股，换手率1.30%，振幅1.24%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.07百万美元，每股收益-0.10美元，毛利0.00美元，市盈率-2.44倍。机构评级方面，在所有5家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为260.45%、175.42%、171.49%，振幅较大的相关个股有Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Protara Therapeutics, Inc.，振幅分别为31.43%、15.88%、9.16%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。该公司管线产品有：Buntanetap 用于治疗慢性神经退行性疾病 - 包括 AD 和 PD； ANVS405治疗急性神经退行性疾病； 以及用于高级 AD 的 ANVS301。消息层面，截至21时31分，《H.C. Wainwright维持Annovis Bio(ANVS.US)买入评级，上调目标价至30美元》资讯为影响Annovis Bio, Inc.的重要信息。该信息摘要如下：H.C. Wainwright分析师Ram Selvaraju维持Annovis Bio 买入评级，并将目标价从23美元上调至30美元。根据TipRanks数据显示，该分析师近一年总胜率为39.8%，总平均回报率为0.4%。TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2450500233"}

Annovis Bio, Inc.盘中异动 早盘快速拉升6.13%报12.82美元

精彩评论

Annovis Bio, Inc.盘中异动早盘快速拉升6.13%报12.82美元